← FDA DRUG APPROVALS

FDA ANDA · ANDA083426

PROMETHAZINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA083426
TYPE
ANDA
ORIGINAL APPROVAL
1973-09-19
LATEST ACTION
2005-06-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PROMETHAZINE HYDROCHLORIDEPrescription
PROMETHAZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

2005-06-09Labeling · Supplement 44AP
2004-12-22Labeling · Supplement 42AP
2001-04-25Manufacturing (CMC) · Supplement 40AP
1998-09-08Manufacturing (CMC) · Supplement 38AP
1997-03-26Manufacturing (CMC) · Supplement 20AP
1991-08-07Manufacturing (CMC) · Supplement 36AP
1991-01-28Manufacturing (CMC) · Supplement 37AP
1990-06-29Manufacturing (CMC) · Supplement 35AP
1989-10-18Labeling · Supplement 34AP
1989-03-29Bioequivalence · Supplement 33AP
1983-12-13Manufacturing (CMC) · Supplement 27AP
1973-09-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →